Wolverine Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15
| Closed | -$1.52K | – | 1571 |
|
|
2023
Q1 | $1.52K | Buy |
+15
| New | +$1.52K | ﹤0.01% | 1324 |
|
|
2021
Q3 | – | Sell |
-1,994
| Closed | -$194K | – | 1934 |
|
|
2021
Q2 | $194K | Buy |
1,994
+1,794
| +897% | +$175K | ﹤0.01% | 1073 |
|
|
2021
Q1 | $19K | Sell |
200
-215
| -52% | -$20.4K | ﹤0.01% | 1517 |
|
|
2020
Q4 | $39K | Buy |
+415
| New | +$39K | ﹤0.01% | 1075 |
|
|
2020
Q3 | – | Sell |
-15
| Closed | -$1K | – | 1421 |
|
|
2020
Q2 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 1177 |
|
|
2019
Q1 | – | Sell |
-2,432
| Closed | -$173K | – | 1170 |
|
|
2018
Q4 | $173K | Buy |
+2,432
| New | +$173K | ﹤0.01% | 836 |
|